Atossa Therapeutics, Inc. (ATOS) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -9.58M | -10.54M | -6M | -7.26M | -5.96M | -7.05M | -4.75M | -4.53M | -4.7M | -5.57M | -3.88M | -4.46M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | -30950% | - | - |
| Operating CF Growth % | -60.78% | -49.47% | -26.42% | -60.21% | -26.84% | -26.57% | -22.33% | -1.48% | 33.1% | -23.17% | 28.23% | 24.95% |
| Net Income | -9.59M | -10.94M | -8.69M | -8.42M | -6.72M | -6.35M | -7.23M | -6.05M | -5.88M | -7.75M | -6.23M | -9.83M |
| Depreciation & Amortization | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 5K | 14K | 3K | 3K |
| Stock-Based Compensation | 0 | 503K | 784K | 796K | 563K | 774K | 749K | 352K | 417K | 519K | 926K | 1.6M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 722K | 0 | 0 | 0 | 0 | 4K | 1.71M | 2K | 2K | 0 | 0 | 2.99M |
| Working Capital Changes | -718K | -109K | 1.9M | 364K | 192K | -1.49M | 18K | 1.16M | 756K | 1.65M | 1.42M | 769K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28K | 709K | 1K |
| Change in Inventory | 0 | 0 | 0 | 0 | 19K | 0 | 0 | 0 | 0 | 2.54M | 0 | 0 |
| Change in Payables | -1.72M | 761K | 1.52M | 845K | 486K | -882K | 505K | -174K | 424K | 88K | -304K | -422K |
| Cash from Investing | 0 | -7K | -7K | 0 | -9K | 0 | -10K | -3K | -6K | 0 | -1K | -13K |
| Capital Expenditures | 0 | -7K | -7K | 0 | -9K | 0 | -10K | -3K | -6K | 0 | -1K | -13K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 0 | 0 | 0 | 0 | 3.37M | 0 | 100K | 204K | 0 | -1.48M | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | 3.37M | 0 | 100K | 204K | 0 | -1.48M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.48M | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -9.58M | -10.55M | -6.01M | -7.26M | -5.97M | -3.68M | -4.76M | -4.43M | -4.5M | -5.57M | -5.36M | -4.48M |
| Free Cash Flow | -9.58M | -10.55M | -6.01M | -7.26M | -5.97M | -7.05M | -4.76M | -4.53M | -4.7M | -5.57M | -3.88M | -4.48M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | -30950% | - | - |
| FCF Growth % | -60.54% | -49.57% | -26.3% | -60.1% | -26.87% | -26.57% | -22.55% | -1.25% | 33.01% | -22.95% | 28.29% | 24.73% |
| FCF per Share | -1.11 | -1.22 | -0.70 | -0.84 | -0.69 | -0.84 | -0.57 | -0.54 | -0.56 | -0.67 | -0.46 | -0.53 |
| FCF Conversion (FCF/Net Income) | 1.00x | 0.96x | 0.69x | 0.86x | 0.89x | 1.11x | 0.66x | 0.75x | 0.80x | 0.72x | 0.62x | 0.45x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |